1-2 of 2
Stefanie Srock
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Results of a Prospective Randomised Open Label Phase III Study Comparing Rituximab Plus Mitoxantrone, Chlorambucile, Prednisolone Chemotherapy (R-MCP) Versus MCP Alone in Untreated Advanced Indolent Non-Hodgkin’s Lymphoma (NHL) and Mantle-Cell-Lymphoma (MCL).

Michael Herold, MD, Rita Pasold, MD, Stefanie Srock, MD, Sabine Neser, MD, Dietger Niederwieser, MD, Andreas Neubauer, MD, Gottfried Dölken, MD, Ralph Naumann, MD, Thomas Fietz, MD, Mathias Freund, MD, Robert Rohrberg, MD, Klaus Hoeffken, MD, Astrid Franke, MD, Thomas H. Ittel, MD, Erika Kettner, MD, Ursula Haak, MD, Ullrich Mey, MD, Christian Klinkenstein, MD, Michael Assmann, MD, Ullrich von Gruenhagen, MD, Klaus Dachselt, MD, Helga Schwenke, MD, Dorothee Bleyl, MD, Heiner Wolf, MD, Sabine Hahnfeld, MD, Franz-Adolph Hoffmann, MD, Volker Lakner, MD, Peter Richter, MD, Detlev Hähling, MD, H. H. Wolf, MD, Henning Eschenburg, MD, M.-R. Clemens, MD, Norbert Grobe, MD
Journal: Blood
Blood (2004) 104 (11): 584.
https://doi.org/10.1182/blood.V104.11.584.584
Published: 2004
Journal Articles

Rituximab therapy of patients with B-cell chronic lymphocytic leukemia

Clinical Trials & Observations
Dieter Huhn, Christoph von Schilling, Martin Wilhelm, Anthony D. Ho, Michael Hallek, Rolf Kuse, Wolfgang Knauf, Ute Riedel, Axel Hinke, Stefanie Srock, Stefan Serke, Christian Peschel, Bertold Emmerich
Journal: Blood
Blood (2001) 98 (5): 1326–1331.
https://doi.org/10.1182/blood.V98.5.1326
Published: 2001